Baumgartner J D, Glauser M P, McCutchan J A, Ziegler E J, van Melle G, Klauber M R, Vogt M, Muehlen E, Luethy R, Chiolero R
Lancet. 1985 Jul 13;2(8446):59-63. doi: 10.1016/s0140-6736(85)90176-x.
The prophylactic effect of antibody to endotoxin core glycolipid was studied in surgical patients at high risk of gram-negative infection. At randomisation (on admission to intensive care unit), every 5 days thereafter, and at onset of septic shock, patients received plasma taken from donors before (control) or after immunisation with Escherichia coli J5, a mutant with only core determinants in its endotoxin. Gram-negative shock occurred in 15 of 136 controls and 6 of 126 J5 antibody recipients and related deaths in 9 of 136 and 2 of 126, respectively. J5 antibody was most effective in abdominal surgery patients, in whom shock occurred in 13 of 83 controls and 2 of 71 antibody recipients. Although antibody prophylaxis did not lower the infection rate, it prevented the serious consequences of gram-negative infections and thus improved the overall prognosis.
对革兰氏阴性菌感染高危手术患者,研究了抗内毒素核心糖脂抗体的预防作用。在随机分组时(入住重症监护病房时)、此后每5天以及发生感染性休克时,患者接受来自未免疫(对照)或用大肠杆菌J5免疫后的供体的血浆,大肠杆菌J5是一种内毒素仅含核心决定簇的突变体。136名对照中有15例发生革兰氏阴性菌休克,126名接受J5抗体者中有6例发生;相关死亡分别为136名对照中有9例,126名接受J5抗体者中有2例。J5抗体在腹部手术患者中最有效,83名对照中有13例发生休克,71名接受抗体者中有2例发生休克。虽然抗体预防并未降低感染率,但它预防了革兰氏阴性菌感染的严重后果,从而改善了总体预后。